This article demonstrates an efficient surgical approach to establish acute ischemia in mice with a small incision. This approach can be applied by most research groups without any laboratory upgrades.
The purpose of this study is to introduce and evaluate a modified surgical approach to induce acute ischemia in mice that can be implemented in most animal laboratories. Contrary to the conventional approach for double ligation of the femoral artery (DLFA), a smaller incision on the right inguinal region was made to expose the proximal femoral artery (FA) to perform DLFA. Then, using a 7-0 suture, the incision was dragged to the knee region to expose the distal FA. Magnetic resonance imaging (MRI) on bilateral hind limbs was used to detect FA occlusion after the surgery. At 0, 1, 3, 5, and 7 days after the surgery, functional recovery of the hind limbs was visually assessed and graded using the Tarlov scale. Histologic evaluation was performed after euthanizing the animals 7 days after DLFA. The procedures were successfully performed on the right leg in ten ApoE-/- mice, and no mice died during subsequent observation. The incision sizes in all 10 mice were less than 5 mm (4.2 ± 0.63 mm). MRI results showed that FA blood flow in the ischemic side was clearly blocked. The Tarlov scale results demonstrated that hind limb function significantly decreased after the procedure and slowly recovered over the following 7 days. Histologic evaluation showed a significant inflammatory response on the ischemic side and reduced microvascular density in the ischemic hind limb. In conclusion, this study introduces a modified technique using a miniature incision to perform hind limb ischemia (HLI) using DLFA.
There is an unmet need for preclinical animal models for research in vascular diseases such as peripheral artery disease (PAD). Despite the advanced developments in diagnosis and treatment, there were more than 200 million patients with PAD in 20181, and their number is constantly increasing. Although several novel therapeutic approaches2,3,4,5,6,7 have been described, successful translation of these therapeutic modalities into clinical application remains a daunting task. Therefore, reliable and relevant in vivo experimental models simulating the human disease condition are required to investigate the potential mechanism and efficiency of these new therapeutic approaches to treat PAD6,7.
Hyperlipidemia and atherosclerosis (AS) are the main risk factors for the development of PAD. ApoE-/- mice (on a high-fat diet) display abnormal fat metabolism and hyperlipidemia and subsequently develop atherosclerotic plaques rendering ApoE-/- mice as the best choice to simulate the clinically relevant PAD. Preclinical HLI animal models are generated through double ligation of the femoral artery (DLFA), which is the most widely used approach in laboratories all over the world8,9,10,11,12,13,14,15 to simulate acute-on-chronic ischemia. However, this approach usually requires a relatively large and invasive incision. Furthermore, it inevitably leads to the animals (especially mice) suffering from increased pain injury and inflammation, which also influences the subsequent experimental results5,6,16,17. This paper describes an acute-on-chronic HLI model in APOE-/- mice by using a very small incision.
NOTE: All experimental procedures were performed according to the EC guideline EC 2010/63/EU and have been approved by the local German legislation (35-9185.81/G[1]239/18). Ten male ApoE-/- mice with the C57BL/6J background, weighing 29.6-38.0 g, were housed on a 12 h light/dark cycle and fed a western diet (1.25% cholesterol and 21% fat) and water ad libitum for 12 weeks from the age of 8 weeks. HLI was performed on 20-week-old mice as described below.
1. Induction of HLI in ApoE-/- mice
2. Magnetic resonance imaging
NOTE: One day after DLFA, the mice must undergo MRI scans to assess FA blockage.
3. Clinical evaluation and follow-up
4. Histologic evaluation
5. Statistical analysis
Characteristics of ApoE-/- mice
DLFA surgeries were successfully performed on 10 mice to establish the HLI model, and none of the mice died after the procedure. To follow changes in body weight, mice were weighed before the DLFA procedure (Pre-DLFA) and 7 days after the DLFA surgery (Post-DLFA). Pre-DLFA weights ranged from 29.6 to 38.0 g (mean 34.74 ± 2.47 g), and post-DLFA weights ranged from 26.5 to 34.1 g (mean 30.77 ± 2.15 g), which were significantly lower than the pre-DLFA weights (P < 0.05, Figure 3A). The time for the surgery ranged from 15 to 47 min (mean 34.2 ± 8.82 min, not including the anesthesia time). The incision size in 10 mice ranged from 3 to 5 mm (mean 4.2 ± 0.63 mm).
MRI scan and functional recovery
The MRI scans very clearly indicated that the proximal and distal regions of the right FA showed no perfusion (Figure 3C), indicating the success of this method. One day after the surgery, the Tarlov Scale results were significantly decreased (P < 0.05). Although the results slowly increased over the following days, they were still lower than baseline until day 7 (P < 0.05, Figure 3B). These trends are consistent with previous reports20. No necrosis or gangrenous tissue development were observed in the bilateral sides of the hind limbs of any mice. However, the paws of the ischemic hind limbs in 7 mice were unable to stretch naturally compared to the contralateral side. In addition, paws of the ischemic hind limbs in 4 mice exhibited slight discoloration compared to the contralateral side (Figure 3D).
Histological analysis
In HE staining of the right Gm muscle, myofibers exhibited irregular ischemic necrosis. Proliferating satellite cells had replaced the necrotic myofibers and were distributed in a mass and/or with irregular dispersion. Myofibers exhibited inflammatory infiltration by multinucleated macrophages. Myofibers in the inflammatory regions had lost their normal morphological characteristics, and there were few regenerated myofibers. Transverse sections of these regenerated myofibers were round, the cytoplasm was stained red, and one small nucleus or multiple nuclei were located at the center. In contrast, this kind of inflammatory pattern was not observed in the left Gm (Figure 4). CD31 antibody staining was performed to identify endothelial cells of the vessel in the Gm samples, and ImageJ was used to evaluate the CD31-positive area – a surrogate for microvascular density-in each of five fields of view (40x) for each sample. Ischemic hind limbs exhibited significantly more microvascular density than the non-ischemic side (P < 0.05, Figure 5).
Figure 1: Equipment and tools required for the experiment. (A) Dissecting microscope and heating pad required for the surgery. (B) Surgical tools: 1. 7-0 and 6-0 absorbable sutures, 2. needle holder, 3. toothless forceps, 4. spring scissors, 5. fine pointed forceps, 6. pointed forceps, and 7. surgical scissors. Please click here to view a larger version of this figure.
Figure 2: Schematic illustration of the procedure. (A and D) A small incision is made on the inguinal region to expose the proximal femoral A, which is ligated. (B and E) A 6-0 suture is used to drag the incision to the knee region to expose the distal Femoral A, which is ligated. (C, F, and G) Stitching of the incision. Abbreviations: Femoral A = femoral artery; Femoral N = femoral nerve; Femoral V = femoral vein. Please click here to view a larger version of this figure.
Figure 3: Characteristics of the PAD mouse model. (A) Comparison of the body weight before and 7 days after DLFA. (B) Functional recovery evaluated by the Tarlov Scale. (C) Magnetic resonance angiography indicates the proximal and distal FA in the left hind limb (white arrow), and on the right side, the proximal and distal FA disappear. (D) Changes in the appearance of the bilateral hind limb of mice No. 2 and No. 4, 1 and 7 days after DLFA. Values shown are mean ± standard deviation. *P < 0.05, ** P < 0.001, *** P < 0.0001, **** P < 0.00001; unpaired t-test. Abbreviations: PAD = peripheral artery disease; DLFA = double ligation of the femoral artery; FA = femoral artery; L = left; R = right. Please click here to view a larger version of this figure.
Figure 4: HE staining of the gastrocnemius muscle. (A) Low-magnification image showing HE staining of the right Gm 7 days after the DLFA procedure. Inflammation was observed in the right Gm. (B) In the right Gm, necrotic myofibers exhibited inflammatory infiltration by macrophages (white arrow). The muscle fibers lose their normal morphological characteristics. There were very few regenerated myofibers (black arrow). (C) HE staining of normal myofibers of the right Gm. (D) The contralateral/left Gm (nonischemic) muscle shows a normal histologic pattern. Scale bars: A = 200 µm, B-D = 50 µm. Abbreviations: HE = hematoxylin-eosin; DLFA = double ligation of the femoral artery; Gm = gastrocnemius; L = left; R= right. Please click here to view a larger version of this figure.
Figure 5: Comparison of the microvascular density of bilateral gastrocnemius muscle. (A) CD31-IHC staining of right Gm section (black arrows). (B) CD31-IHC staining of left Gm section (black arrows). (C) Quantification of the microvascular density of the right side, which was much less than that on the left side. Values shown are mean ± standard deviation. **** P < 0.00001; unpaired t-test. Scale bars: A, B = 20 µm. Abbreviations: CD31 = cluster of differentiation 31; IHC = immunohistochemical; Gm = gastrocnemius. Please click here to view a larger version of this figure.
Tarlov Score | 0 | No movement |
1 | Barely perceptible movement, non-weight bearing | |
2 | Frequent movement, non-weight bearing | |
3 | Supports weight, partial weight bearing | |
4 | Walks with mild deficit | |
5 | Normal but slow walking | |
6 | Full and fast walking |
Table 1: Functional Scoring.
Supplemental Table S1: Summary of 25 papers from the current literature on the establishment of the PAD model. Please click here to download this Table.
This study reports a modified, simplified, and surgically efficient approach to establish an HLI model in ApoE-/- mice using double ligation in the proximal and distal regions of the FA through a 3-4 mm incision without any required laboratory upgrades. The main characteristic of this method is the smaller size of the incision compared to previously reported studies describing mouse HLI models8,9,10,11,12,15,20,22,23,24 .
Historically, an incision has been made from the knee to the media tight, inguinal, or even the abdomen for better exposure, ranging from 0.5 to 2 cm or more9,11,15,19,22,25,26 (summarized in Supplemental Table S1). This paper describes a surgical technique to achieve DLFA and as a result, HLI, in mice with an incision < 5 mm (4.2 ± 0.63 mm). The FA was ligated before it branches into the popliteal artery and saphenous artery, causing ischemia in several muscle groups in the hind limb and resulting in moderate stress in mice. Although mice recovered functionally by 7th day post-operation (Tarlov score day before operation 6 ± 0, 1st day after the operation 3.9 ± 0.99 vs 7th day after the operation 5.2 ± 0.92), ischemic damage was observed in Gm at the histological level. First, Gm in the ischemic leg myofibers exhibited irregular ischemic necrosis and were infiltrated by multinucleated macrophages, similar to what has been reported in PAD patients27,28. Despite myofiber atrophy, a few regenerated myofibers were also observed, which is in line to a previous report29. Second, the microvascular density in the ischemic Gm on the 7th day after ligation was higher than in the non-ischemic leg, which has also been reported by Ministro et al.30. The recent focus in PAD therapy is not just limited to increase microvascular density compared to the non-ischemic side, but also on the restoration of ischemia-induced loss of viable muscle tissue, which supports new vessel formation by providing a matrix of growth factors and biomechanical support31. Thus, this model also gives a wide window to test the effectiveness of new therapies with these foci. Furthermore, achieving HLI with smaller incision fits with the 3R concept of animal experimentation as a refinement of the surgical procedure, i.e., the small skin incisional size decreases the trauma and postoperative pain.
An ideal animal model also provides a relatively long therapeutic window. Various surgical procedures for establishing ischemia in mice have been reported and applied, and they exert different effects on blood flow restoration21. For induction of HLI, surgical methods normally focus on the iliac artery12,19,23,32, femoral artery24,33,34, and their branches11,35, some including the femoral vein as well36,37. As the level of vascular ligation has no effect on blood flow restoration, the deciding factor is the extent of injury in the vascular tree21. For a single ligation of the femoral or iliac artery, a small incision is made in the inguinal or abdominal region, while the other branch interactions are still maintained, and the perfusion restoration in the mouse hind limb recovers completely within 7 days21,38. Thus, a single ligation is not sufficient in terms of providing a suitable therapeutic window to test the effects of different treatments. If branches from the FA also need to be ligated, the skin incision must be made even larger, which lengthens the surgical time. Therefore, HLI by DLFA in mouse offers a suitable therapeutic window in which the improvements induced by therapy can be efficiently monitored9,21,22,25.
Establishing a clinically relevant HLI animal model is important to test the efficiency of novel therapeutic approaches, i.e., cell, stem cell, or gene therapy for PAD2,3,4. Several PAD models have been developed in mice15,21, rats39, and rabbits40,41. Del Giudice and colleagues established a rabbit hindlimb ischemia model created by percutaneous, transauricular, distal femoral artery embolization with calibrated particles that may overcome some of the limitations of existing animal models40. Liddell et al.41 also created a rabbit PAD model by coiling the superficial FA through an endovascular approach, resulting in reduced hind limb reperfusion. Although larger animals, such as rabbits, may yield more convincing results40,41, taking the therapies a step closer to clinical application, however they require increased cost and time to obtain results.
Despite the heterogeneous risk profile of most patients with PAD, including hereditary and behavioral factors42, ApoE-/- mice exhibit abnormal fat metabolism and hyperlipidemia symptoms, such as total cholesterol, triglycerides, very-low-density lipoprotein, and intermediate-density lipoprotein, replicating some of the main characteristics observed in patients with PAD. Furthermore, with the high-fat diet, these indicators significantly increase. Lo Sasso et al. reported that in these mice, arterial fat accumulation occurs at 3 months of age43, and that an increase in AS lesions occurs with advancing age43. Thus, ApoE-/- mice are particularly well-suited for the acute-on-chronic ischemia-PAD model because they recapitulate the hypercholesterolemia commonly present in patients with PAD and provide a suitable platform to evaluate various therapies targeted at promoting neovascularization of ischemic limbs. Furthermore, the price-performance ratio of testing novel therapies with ApoE-/- mice is unbeatable.
Despite the advantages mentioned in the above paragraphs, there are two limitations to this model. First, mastering this method requires the experimenter to have sufficient microsurgical experience and familiarity with the anatomy of the mouse hind limb. Second, the limited surgical exposure and the amount of subcutaneous fat tissue in the hind limb of ApoE-/- mice increase the surgical difficulty. Therefore, some related practice is required for successful implementation of this technique. In conclusion, this study reports a modified and easy-to-implement, surgically efficient approach for establishing an HLI model in ApoE-/- mice using a small incision. The small incision significantly reduces trauma to the animal and can be applied by most research groups without any laboratory upgrades.
The authors have nothing to disclose.
Authors thank Viktoria Skude, Alexander Schlund, and Felix Hörner for the excellent technical support.
10x Phosphate buffer saline | Roth | 9143.1 | Used for haematoxylin and eosin stain and immunohistochemistry stain |
30% H2O2 | Roth | 9681.2 | Used for immunohistochemistry stain |
6-0 absorbable sutures | PROLENE | 8776H | Used for stitching the skin |
6-0 absroable suture | PROLENE | EP8706 | Used in Surgery |
7-0 absorbable sutures | PROLENE | EH8021E | Used for ligating the artery |
7-0 absroable suture | PROLENE | EP8755 | Used in Surgery |
Acetic acid | Roth | 6755.1 | Used for haematoxylin and eosin stain |
Albumin Fraktion V | Roth | 8076.2 | Used for immunohistochemistry stain |
Autoclave | Systec GmbH | Systec VX-150 | Used for the sterilisation of the surgical instruments |
Axio vert A1 microscope | Carl Zeiss | ZEISS Axio Vert.A1 | Used for viewing and taking the pictures from haematoxylin and eosin stain and immunohistochemistry stain |
Bruker BioSpec 94/20 AVIII | Bruker Biospin MRI GmbH | N/A | Scan the femoral artery blockage |
Buprenovet Sine 0,3mg/ml | Bayer AG | 2542 (WDT) | Used in post operative pain-management. Dose – 0.1 mg/kg body weight every 8 hours for 48 h after operation |
CD31 antibody | Abcam | ab28364 | Used for immunohistochemistry stain |
Eosin Y solution 0.5 % in water | Roth | X883.1 | Used for haematoxylin and eosin stain |
Epitope Retrieval Solution pH 6 | Leica Biosystems | 6046945 | Used for immunohistochemistry stain |
Ethanol ≥ 99,5 % | Roth | 5054.1 | Used for haematoxylin and eosin stain and immunohistochemistry stain |
Fentanyl | Cayman Chemical | 437-38-7 | Used for anesthesia |
Fine point forceps | Medixplus | 93-4505S | Used for separating the artery from nerve and vein |
Glass bead sterilisator | Simon Keller | Type 250 | Used for sterilisation of the surgical instruments |
Graefe iris forceps curved | VUBU | VUBU-02-72207 | Used for blunt separation of skin and subcutaneous tissue |
Hair Remover cream, Veet (with aloe vera) | Reckitt Benckiser | 108972 | Remove hair from mice hind limbs |
Heating plate | STÖRK-TRONIC | 7042092 | Keep the satble temperature of mice |
Hematoxylin | Roth | T865.2 | Used for haematoxylin and eosin stain and immunohistochemistry stain |
Leica surgical microscope | Leica | M651 | Enlarge the field of view to facilitate the operation |
Liquid DAB+Substrate Chromogen System | Dako | K3468 | Used for immunohistochemistry stain |
Male ApoE-/- mice | Charles River Laboratories | N/A | Used for establish the Peripheral artery disease mice model |
Medetomidine | Cayman Chemical | 128366-50-7 | Used for anesthesia |
Micro Needle Holder | Black & Black Surgical | B3B-18-8 | Holding the needle |
Micro suture tying forceps | Life Saver Surgical Industries | PS-MSF-145 | Used to assist in knotting during surgery |
Microtome | Biobase | Bk-Mt268m | Used for tissue sectioning |
Midazolam | Ratiopharm | 44856.01.00 | Used for anesthesia |
MR-compatible Small Animal Monitoring and Gating System Model 1025 | SA Instruments | N/a | monitoring vital signs of animal during MRI scan |
Octeniderm farblos | Schülke & Mayr GmbH | 180212 | used for disinfection of the skin |
Ointment for the eyes and nose | Bayer AG | 1578675 | Keep the eyes wet under the anesthesia |
Paraformaldehyde | Roth | 0335.1 | Used for fixation of the tissue |
Pentobarbital | Nembutal | 76-74-4 | Used for anesthesia |
Saline | DeltaSelect | 1299.99.99 | Used for anesthesia |
Spring handle scissors with fine, sharp tips | Black & Black Surgical | B66167 | Used for cutting the artery |
SuperCut Scissors | Black & Black Surgical | B55992 | Used for cutting the skin |
Triton X-100 | Roth | 9002-93-1 | Used for immunohistochemistry stain |
Western diet, 1.25% Cholesterol | ssniff Spezialdiäten GmbH | E15723-34 | Diet for the mice |
Xylene | Roth | 4436.3 | Used for haematoxylin and eosin stain and immunohistochemistry stain |